Afya (AFYA) 3-Year Revenue Growth Rate : 37.50% (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Afya 3-Year Revenue Growth Rate?

Afya's Revenue per Share for the three months ended in Dec. 2023 was $1.64.

During the past 12 months, Afya's average Revenue per Share Growth Rate was 32.40% per year. During the past 3 years, the average Revenue per Share Growth Rate was 37.50% per year. During the past 5 years, the average Revenue per Share Growth Rate was 40.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 7 years, the highest 3-Year average Revenue per Share Growth Rate of Afya was 49.40% per year. The lowest was 26.80% per year. And the median was 43.15% per year.

Competitive Comparison of Afya's 3-Year Revenue Growth Rate

For the Education & Training Services subindustry, Afya's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Afya's 3-Year Revenue Growth Rate Distribution in the Education Industry

For the Education industry and Consumer Defensive sector, Afya's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Afya's 3-Year Revenue Growth Rate falls into.

Afya 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Afya (NAS:AFYA) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Afya 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Afya's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Afya (AFYA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Education » Afya Ltd (NAS:AFYA) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

1AY:Germany 1AY:Germany A2FY34:Brazil

Address

Alameda Oscar Niemeyer, No. 119, Room 504, Vila da Serra, Nova Lima, MG, BRA

Website

https://www.afya.com.br

Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergrad provides educational services through undergraduate courses related to medicine, other health sciences, and other undergraduate programs, Continuing Education provides specialization programs and graduate courses in medicine; and Digital Services provides content and technology for medical education, clinical decisions software, practice management tools (that encompass electronic medical records, telemedicine, and digital prescription, and provides access, demand and efficiency for the healthcare players.